Company Filing History:
Years Active: 2007
Title: Montserrant Monsalvatje Llagostera: Innovator in Pharmaceutical Chemistry
Introduction
Montserrant Monsalvatje Llagostera is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of processes for synthesizing important compounds. His work has implications for the treatment of hypertension, showcasing the intersection of innovation and healthcare.
Latest Patents
Llagostera holds a patent for a process titled "Process for obtaining quinapryl hydrochloride and solvates useful for isolating and purifying quinapryl hydrochloride." This innovative process involves several stages, including hydrogenolysis of the benzyl ester of quinapril, solvent removal, and the precipitation of quinapril hydrochloride as a toluene solvate. The final steps ensure the production of quinapril hydrochloride, an effective antihypertensive agent.
Career Highlights
Llagostera is associated with Esteve Quimica S.A., a company known for its commitment to pharmaceutical innovation. His work there has been instrumental in advancing methods for drug synthesis, contributing to the company's reputation in the industry. With a focus on practical applications, Llagostera's inventions are paving the way for improved therapeutic options.
Collaborations
Llagostera has collaborated with esteemed colleagues such as Marti Bartra Sanmarti and Jaime Thomas Navarro. These partnerships have fostered a collaborative environment that enhances the research and development of pharmaceutical processes.
Conclusion
Montserrant Monsalvatje Llagostera exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the synthesis of quinapril hydrochloride, highlight the importance of research and collaboration in advancing healthcare solutions.